Answers are grounded in this paper and cite their sources.
Analysis identifies 26 vibsane diterpenoids, including antihepatoma compounds targeting MAPKAPK2.
Through a MassQL-integrated strategy, 26 vibsane diterpenoids (VibDs) were identified from Viburnum awabuki, including 15 new compounds (1-15) and 11 known analogues (16-26). Compound 1 possessed an unprecedented seven-membered ring scaffold, representing a new type of VibD. The hypothetical biosynthetic pathway of 1 was proposed. Notably, 18 could exert the antihepatoma effect by targeting MAPKAPK2, thereby suppressing its kinase activity and subsequent phosphorylation of HSP27 in vitro and in vivo.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: